Last reviewed · How we verify

NCT03292367

The Procedural Success and Complication Rate of the Left Distal Radial Approach

Completed Last updated 8 May 2018
What this trial tests

trial testing ldTRA in Coronary Artery Disease in 200 participants. Completed in 24 February 2018.

Timeline
11 October 2017
Primary endpoint
19 February 2018
24 February 2018

Quick facts

Lead sponsorWonju Severance Christian Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date11 October 2017
Primary completion19 February 2018
Estimated completion24 February 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Wonju Severance Christian Hospital

Who can join

20 and older, any sex, with Coronary Artery Disease or Radial Artery Injury at Wrist and Hand Level. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Left distal transradial approach (ldTRA) can be an attractive alternative route for left radial and right radial artery. Recently, Ferdinand Kiemeneij reported the feasibility and safety of the use of ldTRA. But, there is few studies focused on this issue. Therefore, the purpose of this prospective observational study is to assess the feasibility and safety of the ldTRA for CAG and PCI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Distal transradial access: a review of the feasibility and safety in cardiovascular angiography and intervention.
    Cai G, Huang H, Li F, Shi G, et al · · 2020 · cited 45× · PMID 32758150 · DOI 10.1186/s12872-020-01625-8

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Wonju Severance Christian Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292367.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing